Targeting programmed cell death 1 receptor (PD-1) expression in lung cancer using a humanized mouse model

被引：0
|
作者：
Jiang, Dawei [1 ]
England, Christopher [1 ]
Ehlerding, Emily [1 ]
Graves, Stephen [2 ]
Hernandez, Reinier [1 ]
Cai, Weibo [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
179
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Expression of programmed death-1 (PD-1) in sentinel lymph nodes of breast cancer
    Mukohara, Toru
    Tatara, Takashi
    Shimono, Yohei
    Yamasaki, Takashi
    Toyoda, Masanori
    Kiyota, Naomi
    Takao, Shintaro
    Kono, Seishi
    Kakeji, Yoshihiro
    Minami, Hironobu
    ANNALS OF ONCOLOGY, 2017, 28
  • [32] Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis
    Alexandra Giatromanolaki
    Ioannis M. Koukourakis
    Konstantina Balaska
    Achilleas G. Mitrakas
    Adrian L. Harris
    Michael I. Koukourakis
    Medical Oncology, 2019, 36
  • [33] Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis
    Giatromanolaki, Alexandra
    Koukourakis, Ioannis M.
    Balaska, Konstantina
    Mitrakas, Achilleas G.
    Harris, Adrian L.
    Koukourakis, Michael I.
    MEDICAL ONCOLOGY, 2019, 36 (09)
  • [34] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1125 - 1125
  • [35] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 219 - 219
  • [36] Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse
    Ashizawa, Tadashi
    Iizuka, Akira
    Nonomura, Chizu
    Kondou, Ryota
    Maeda, Chie
    Miyata, Haruo
    Sugino, Takashi
    Mitsuya, Koichi
    Hayashi, Nakamasa
    Nakasu, Yoko
    Maruyama, Kouji
    Yamaguchi, Ken
    Katano, Ikumi
    Ito, Mamoru
    Akiyama, Yasuto
    CLINICAL CANCER RESEARCH, 2017, 23 (01) : 149 - 158
  • [37] Targeting programmed cell death protein 1 (PD-1) for treatment of non-small-cell lung carcinoma (NSCLC); the recent advances
    Dehghani, Tannaz
    Shahrjerdi, Alireza
    Kahrizi, Mohammad Saeed
    Soleimani, Elnaz
    Ravandeh, Saeideh
    Merza, Muna S.
    Rahnama, Negin
    Ebrahimzadeh, Farnoosh
    Bakhshesh, Morteza
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 246
  • [38] Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer A Meta-Analysis
    Zhang, Yaxiong
    Kang, Shiyang
    Shen, Jianfei
    He, Jiaxi
    Jiang, Long
    Wang, Wei
    Guo, Zhihua
    Peng, Guilin
    Chen, Gang
    He, Jianxing
    Liang, Wenhua
    MEDICINE, 2015, 94 (06) : e515
  • [39] Gene expression of programmed cell death (PD-1) and its ligand, PD-L1, in primary epithelial ovarian cancer
    Talukdar, S.
    Cepela, J.
    Chang, Z.
    Zhang, Y.
    Grad, A.
    Mullany, S. A.
    Starr, T.
    Winterhoff, B.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 254 - 254
  • [40] Association of the programmed cell death 1 (PD-1) receptor, programmed death ligand 1 (PD-L1), and androgen receptor (AR) with PARPi-7 and DNA damage repair gene expression in primary breast cancer (BC)
    Vidula, N.
    Wolf, D.
    Yau, C.
    Rugo, H. S.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S65 - S65
12345